CLDN3 and ovarian cancer: On the basis of the high expression of claudin-3 and/or claudin-4 detected by RT-PCR in primary ovarian cancer cell lines we predicted that the FITC-conjugated CPE peptide may bind to ovarian tumors in vitro.